Abstract:Tetrandrine, a bisbenzylisoquinoline alkaloid isolated from the roots of Stephania tetrandra is a traditional Chinese medicine and exerts anticancer capacity in various types of cancers. Previous studies have shown that tetrandrine induces apoptosis in bladder cancer cells via activation of the caspase cascade. However, the underlying mechanism has not yet been reported. Autophagy is a cellular process involved in the degradation of broken proteins and aging organelles to maintain homeostasis. Recent studies indicate that autophagy is implicated in cancer therapy. Thus, we focused on the correlation between autophagy and apoptosis upon tetrandrine treatment in human bladder cancer cells. Firstly, our results observed a marked increase in autophagic double-membrane vacuoles and fluorescent puncta of red fluorescence proteingreen fluorescence protein-LC3 (GRP-RFP-LC3) upon tetrandrine treatment, as evidenced by transmission electron microscopy and confocal fluorescence microscopy. Secondly, the expression of LC3-II was increased in tetrandrine-treated T24 and 5637 cells in a time-and concentration-dependent manner. Subsequently, downregulation of p62 and LC3 turnover assay further confirmed that tetrandrine induced autophagic flux in bladder cancer T24 and 5637 cells. Thirdly, the protein levels of phosphorylated-AMP-activated protein kinase (AMPK) and phosphorylated-acetyl-coenzyme A carboxylase (ACC) were upregulated in the tetrandrine-treated cells, while the mammalian target of rapamycin (mTOR)related proteins were downregulated. Moreover, AICAR, a common AMPK activator, further increased the expression the LC3-II, while AMPK inhibitor compound C partially reversed the LC3-II protein levels in bladder cancer T24 cells. Finally, AICAR significantly reinforced the growth inhibition and apoptosis induction of tetrandrine in T24 and 5637 cells, while compound C had an opposite effect, suggesting that AMPK-mediated autophagy enhanced the cytotoxic and pro-apoptosis effect of tetrandrine in human bladder cancer cells. Taken together, the present study showed that tetrandrine induced autophagy in human bladder cancer cells by regulating the AMPK/mTOR signaling pathway, which contributed to the apoptosis induction by tetrandrine, indicating that tetrandrine may be a potential anticancer candidate for the treatment of bladder cancer, and autophagy may be a possible mechanism for cancer therapy.

Tetrandrine Inhibits Proteasomal Chymotrypsin-Like Activity and Induces Apoptosis in Human PC-3 Cells

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Tetrandrine Suppresses Proliferation, Induces Apoptosis, and Inhibits Migration and Invasion in Human Prostate Cancer Cells.

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells

TGF-β1/PTEN/PI3K Signaling Plays a Critical Role in the Anti-Proliferation Effect of Tetrandrine in Human Colon Cancer Cells.

Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells.

Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells.

Tetrandrine Suppresses Cervical Cancer Growth by Inducing Apoptosis in Vitro and in Vivo

Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer

Tetrandrine Induces Apoptosis Via Caspase-8, -9, and -3 and Poly (ADP Ribose) Polymerase Dependent Pathways and Autophagy Through Beclin-1/ LC3-I, II Signaling Pathways in Human Oral Cancer HSC-3 Cells.

Tetramethylpyrazine hydrochloride inhibits proliferation and apoptosis in human prostate cancer PC3 cells through Akt signaling pathway

Tetrandrine Induces Programmed Cell Death in Human Oral Cancer CAL 27 Cells Through the Reactive Oxygen Species Production and Caspase-Dependent Pathways and Associated with Beclin-1-induced Cell Autophagy.

Autophagy Induction Enhances Tetrandrine-Induced Apoptosis Via the AMPK/mTOR Pathway in Human Bladder Cancer Cells

Synergistic Anti‐tumour Effects of Tetrandrine and Chloroquine Combination Therapy in Human Cancer: a Potential Antagonistic Role for P21

Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species

A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability

Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway

Study on the efficacy of Tetrandrine in inducing the apoptosis of neuroblastoma cells

Tetrandrine Suppresses Human Glioma Growth by Inhibiting Cell Survival, Proliferation and Tumour Angiogenesis Through Attenuating STAT3 Phosphorylation.

Camptothecin derivatives induce apoptosis and inhibit proliferation of prostate cancer PC-3M cells through downregulation of PI3K/Akt signaling pathway

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines